<DOC>
	<DOC>NCT01442402</DOC>
	<brief_summary>Aim 1: Determine if there is an association between the APOL1 risk variants and allograft survival and function in African Americans Aim 2: Determine if there is an association between the presence of APOL1 risk variants in an African American kidney transplant recipient and the risk of recurrent disease Aim 3: Investigate mechanisms of APOL1 associated kidney disease by prospectively following African American kidney transplant recipients throughout their clinical course.</brief_summary>
	<brief_title>APOL1 Gene Variants in African American Kidney Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<criteria>Aim 1: selfreported African American 18 years or older kidney transplant within 12 years Aim 2: Inclusion Criteria for patients with recurrent disease: selfreported African American 18 years or older kidney transplant within 12 years recurrent or de novo glomerular disease on allograft kidney biopsy Inclusion Criteria for control group: selfreported African American 18 years or older kidney transplant within 12 years end stage kidney disease due to glomerular nephritis, clinically diagnosed or by native kidney biopsy Exclusion Criteria for control group: clinical evidence of recurrent disease (presence of proteinuria, hematuria, Creatinine &gt;2) Aim 3: selfreported African American 18 years or older scheduled living kidney transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>